Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stantec (STN) Accounts Payables (2016 - 2025)

Historic Accounts Payables for Stantec (STN) over the last 16 years, with Q3 2025 value amounting to $1.2 billion.

  • Stantec's Accounts Payables rose 6052.4% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 6052.4%. This contributed to the annual value of $744.1 million for FY2024, which is 1917.16% up from last year.
  • Per Stantec's latest filing, its Accounts Payables stood at $1.2 billion for Q3 2025, which was up 6052.4% from $889.7 million recorded in Q2 2025.
  • In the past 5 years, Stantec's Accounts Payables ranged from a high of $1.2 billion in Q3 2025 and a low of -$82.1 million during Q1 2021
  • Its 5-year average for Accounts Payables is $692.0 million, with a median of $723.8 million in 2024.
  • In the last 5 years, Stantec's Accounts Payables tumbled by 11628.32% in 2021 and then surged by 82155.91% in 2022.
  • Over the past 5 years, Stantec's Accounts Payables (Quarter) stood at $503.5 million in 2021, then rose by 10.56% to $556.7 million in 2022, then grew by 11.14% to $618.8 million in 2023, then rose by 17.85% to $729.2 million in 2024, then surged by 59.33% to $1.2 billion in 2025.
  • Its Accounts Payables was $1.2 billion in Q3 2025, compared to $889.7 million in Q2 2025 and $898.3 million in Q1 2025.